000 | 01258 a2200301 4500 | ||
---|---|---|---|
005 | 20250513222821.0 | ||
264 | 0 | _c20010329 | |
008 | 200103s 0 0 eng d | ||
022 | _a1043-2760 | ||
024 | 7 |
_a10.1016/s1043-2760(00)00311-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchmidt, A M | |
245 | 0 | 0 |
_aRAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. _h[electronic resource] |
260 |
_bTrends in endocrinology and metabolism: TEM _cNov 2000 |
||
300 |
_a368-75 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDiabetes Complications |
650 | 0 | 4 |
_aDiabetic Angiopathies _xdrug therapy |
650 | 0 | 4 |
_aGlycation End Products, Advanced _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 | _aReceptor for Advanced Glycation End Products |
650 | 0 | 4 |
_aReceptors, Immunologic _xdrug effects |
700 | 1 | _aStern, D M | |
773 | 0 |
_tTrends in endocrinology and metabolism: TEM _gvol. 11 _gno. 9 _gp. 368-75 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1043-2760(00)00311-8 _zAvailable from publisher's website |
999 |
_c10987462 _d10987462 |